AP Pharma Reports 2006 First Quarter Results; Phase 3 Clinical ... May 10, 2006APF530 contains the 5HT(3) antagonist anti-nausea drug granisetron formulated with the Company's proprietary Biochronomer(TM) drug delivery system. ... - Genetic Engineering News,
